baber/WOPTO huggingface dataset:
Patent FI-904395-A0 (FI)
Inventor: JENDRALLA HEINER
IPC: C07C39/08
Filed: 1990-09-06
Abstract: Compounds of the formula I 
<IMAGE>
 and the corresponding open-chain dihydroxy carboxylic acids of the formula II 
<IMAGE>
 in which X, Y, R<1>, R<2>, R<3>, R<4>, R<5> have the stated meanings, and their pharmacologically acceptable salts with bases and their pharmacologically acceptable esters, process for the preparation of these compounds, their use as drugs, and pharmaceutical preparations are described. Also described are compounds of the formula III 
<IMAGE>
 in which R<1>, R<2>, R<3>, R<4>, R<5>, X and Y have the stated meanings.
Patent FI-910148-A0 (FI)
Inventor: HERNESTAM SVEN
IPC: C07D265/00
Filed: 1991-01-11
Abstract: PCT No. PCT/SE90/00323 Sec. 371 Date Feb. 19, 1991 Sec. 102(e) Date Feb. 19, 1991 PCT Filed May 14, 1990 PCT Pub. No. WO90/14342 PCT Pub. Date Nov. 29, 1990.The invention concerns intermediates having the formula   <IMAGE> IV-anti  <IMAGE> IV-syn  <IMAGE> V  wherein R is 2-propylpentyl optionally with one, two or three internal unsaturated bonds, or 2-substituted-2-propylpentyl optionally with one or two internal unsaturated bonds wherein the 2-substituent is a leaving group.
Patent FI-910258-A0 (FI)
Inventor: PETTERSSON HENRIK
IPC: F16L55/033
Filed: 1991-01-17
Abstract: The invention concerns a sound attenuator for low frequencies for air-condiboning ducts, in particular for intake-air and/or exhaust-air ducts in paper mills. The sound attenuator comprises a frame (20), whose flow duct substantially coincides with the air-conditioning duct and in which frame (20) there is at least one plane attenuator member (30) parallel to the flow direction and consisting of one or several attenuator units operating by the Helmholtz and/or plate resonator principle. The attenuator member or members (30) are fitted in the frame (20) singly or as a group of several attenuator members to be replaced for cleaning and/or servicing of the sound attenuator and/or of the attenuator members. <IMAGE>
Patent FI-911780-A0 (FI)
Inventor: COY DAVID H
IPC: A61K38/22
Filed: 1991-04-12
Abstract: In general, the invention features a linear (i.e., non-cyclic) bombesin analog of biologically active mammalian gastrin-releasing peptide (GRP) and amphibian bombesin, having an active site and a binding site responsable for the binding of the peptide to a receptor on a target cell; cleavage of a peptide bond in the active site of naturally occuring bombesin or GRP is unnecessary for in vivo bilogical activity. The analog has one of the following modifications: (a) a deletion of a residue within the active site and a modification of a residue outside of the active site, or (b) a remplacement of one or two residues within the active site with a synthetic amino acid. The analog is capable of binding to the receptor and acting as a competitive inhibitor of the naturally occurring peptide by binding to the receptor and, by virtue of one of the modifications, failing to exhibit the in vivo biological activity of the naturally occurring peptide.
Patent FI-920716-A0 (FI)
Inventor: REIL WILHELM
IPC: B65D51/20
Filed: 1992-02-19
Abstract: A pouring device (10) made of plastic for mounting on a hole in a package for flowable contents and a method of manufacturing such a device are described. In order to close a hole of differently shaped packages easily and in order to guarantee the storage and transportation of such a fluid package without the risk of leakage, but on the other hand also to provide easy openability for the user and, in terms of the method, to operate with a large machine manufacturing capacity, provision is made according to the invention for the pouring device (10) to have a lower part (20) and a closure part (21), which parts are connected to one another via a hinge (22) with moveable linking, and for a pouring opening to be provided in the lower part (20), a plastic film (51) being mounted so as to extend beyond the lower part and the pouring opening. 
<IMAGE>
Patent FI-930072-A0 (FI)
Inventor: MAGRUDER JUDY A
IPC: A61K/
Filed: 1993-01-08
Abstract: This invention relates to an active agent delivery device. More particularly, the invention relates to a delivery device that includes a sleeve to protect the delivery device from transient mechanical forces. The delivery device of the invention is robust and resistant to transient mechanical forces. The invention provides a fluid-imbibing delivery device comprising a housing enclosing an internal compartment, said housing having a first wall section that substantially restricts the passage of fluid into the delivery device, i.e. is substantially fluid-impermeable, and that contains a beneficial agent; a second wall section that permits the passage of fluid into the delivery device, i.e. is fluid-permeable, and that contains at least one expandable driving member; and exit means; with a protective sleeve means extending from the first wall section of the housing to cover and protect the second wall section of the housing and the junction of the first and second sections. The protective sleeve is preferably configured to provide substantially no resistance to flow of fluid or fluid vapors through the fluid-permeable second wall section.
Patent FI-943643-A0 (FI)
Inventor: FOUQUE ELIE
IPC: C07D305/14
Filed: 1994-08-05
Abstract: This invention relates to a method for preparing taxane derivatives of general formula (I)by esterification at a temperature between -10 and 60° C. of a derivative of baccatine III or 10-deacetyl baccatine III of general formula (II)by means of an acid of general formula (III),followed by replacement of the protective groupings G1, G2 and R2 of the resulting product by hydrogen atoms. In formulae (I), (II) or (III), Ar stands for an aryl radical; R stands for hydrogen or acetyl; R1 is benzoyl or ter.butoxycarbonyl; G1 is a hydroxy function protective grouping, G2 stands for the acetyl radical or a hydroxy function protective grouping, and R2 stands for a hydroxy function protective grouping.
Patent FI-953704-A0 (FI)
Inventor: EDENS JR ROY C
IPC: D21F7/10
Filed: 1995-08-03
Abstract: A composite pintle for joining the ends of a pin-seamable papermaker's fabric together with a pin seam includes a monofilament yarn having at least one monofilament strand, and a filler yarn, so-called because it fills the void volume surrounding the monofilament yarn in the passage formed by the interdigitated seaming loops and through which the composite pintle is directed to join the fabric into endless form. The filler yarn, including sample fibers, may be a texturized, spun, cabled or plied yarn. The monofilament and filler yarns are drawn through the seaming passage by a wire leader, which may be attached to them by a connecting sleeve.
Patent FI-962034-A0 (FI)
Inventor: PROPACH DAVID S
IPC: H04N1/411
Filed: 1996-05-13
Abstract: In a method for minimizing a data bottleneck in a Low Data Rate Network (LDRN) (34), i.e. a facsimile network having a transmission rate less than the data rate of the facsimile machines serviced by the network, the LDRN (34) has a one-dimensional image data format and a two-dimensional image data format. The method comprises processing the facsimile transmissions in order to make the data rates of the LDRN and the FAX machines compatible, thereby minimizing any potential facsimile data bottlenecks that may occur in the LDRN due to its slower data rate. In the method, a first facsimile (FAX) machine (12) is set to the one-dimensional image data format; a data stream encoded in the one-dimensional image data format is sent (32) from the first FAX machine (12) to a first side of the LDRN (34); the data stream sent is uncompressed, and the uncompressed data stream is re-encoded into the two-dimensional image data format; the re-encoded data stream is transmitted from the first side of the LDRN (34) to a second side of the LDRN (34); the transmitted data stream is second uncompressed; the second uncompressed data stream is second re-encoded into the one-dimensional image data format; and the re-encoded data stream is second sent (36) from the second side of the LDRN (34) to a second FAX machine (16).
Patent IL-58050-A0 (IL)
Title: N-oxalyl derivatives of n-phenyl aminoacids and n-phenyl-aminoacid esters their preparation and their use as fungicides
IPC: A01N43/20
Filed: 1979-08-15
Abstract: N-oxalyl-N-phenyl-aminoacid or ester thereof of the formula <IMAGE>  (I)  in which: R1 represents hydrogen, alkyl or halogen, R2 represents hydrogen or alkyl, R3 represents hydrogen or alkyl, R4 represents hydrogen, alkyl or optionally substituted phenyl, R5 represents hydrogen, alkyl, cyanoalkyl, alkenyl, alkynyl, halogenoalkyl, cycloalkyl, cycloalkylalkyl, alkoxyalkyl, alkoxyalkoxyalkyl, alkoxycarbonylalkyl, alkylthioalkyl, alkylsulphinylalkyl, alkylsulphonylalkyl, dialkylaminoalkyl, optionally substituted aryl or optionally substituted aralkyl and R6 represents alkyl, cyanoalkyl, alkenyl, alkynyl, halogenoalkyl, cycloalkyl, cycloalkylalkyl, alkoxyalkyl, alkoxyalkoxyalkyl, alkoxycarbonylalkyl, alkylthioalkyl, alkylsulphinylalkyl, alkylsulphonylalkyl, dialkylaminoalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted aroxyalkyl, epoxyalkyl or a grouping of the formula   <IMAGE>   wherein R7, R8 and R9, which need not be identical, each represent alkyl, X represents alkylene or alkylidene Y represents oxygen or sulphur and Z represents the anion of an inorganic or organic acid, which possess fungicidal properties.
Patent IL-74631-A0 (IL)
Title: 3-substituted 2-oxindole-1-carboxamides and pharmaceutical compositions containing them
IPC: C07D513/04
Filed: 1985-03-18
Abstract: 2-Oxindole-1-carboxamides of the formula: 
<CHEM>
 and their pharmaceutically acceptable base-salts, where X and Y are certain optional substituents or can be taken together to form certain ring structures; and R<1> is alkyl, cycloalkyl, cycloalkenyl, optionally substituted phenyl, optionally substituted phenylalkyl, optionally substituted phenoxyalkyl, (thiophenoxy) alkyl, naphthyl, bicyclo [2.2.1]heptan-2-yl, bicyclo [2.2.1]hept-5-en-2-yl or a group of the formula -(CH2)n-Q-R<0> where n is 0, 1 or 2, Q is a divalent radical which is a specified heterocycle, and R<0> is H or alkyl. 
<??>The compounds are useful as analgesic and anti-inflammatory agents. 
<??>Also covered are certain intermediates useful in the preparation of the compounds (I), these intermediates having H in place of -COR<1>.
Patent IL-81734-A0 (IL)
Title: Vaccine against herpes simplex
IPC: A61K39/245
Filed: 1987-03-02
Abstract: A vaccine against human herpes simplex virus comprises the virus particles of bovine mammalitis virus. The vaccine is prepared by infecting a serum-starved cell line with bovine mammalitis virus, incubating the infected cells in a suitable medium and separating the incubation medium whcih contains the virus particles. The vaccine may comprise either live or inactivated virus particles.
Patent IL-82468-A0 (IL)
Title: Liquid/liquid extractions with microporous membranes
IPC: B01D61/00
Filed: 1987-05-10
Abstract: The rate of mass transfer in liquid/liquid extractions can be increased by the appropriate selection of a solubilizing liquid to wet a microporous membrane. A solute is transferred between immiscible liquids across the membrane where an interface between the liquids is immobilized at a surface of the membrane.
Patent IL-86268-A0 (IL)
Title: Viral glycoprotein subunit vaccine
IPC: A61K39/155
Filed: 1988-05-03
Abstract: Method for immunizing against viral infection by administering intranasally an immunogenically effective amount of a viral envelope subunit vaccine comprising a glycoprotein complexed with a lipid.
Patent IL-99016-A0 (IL)
Title: Method of extracting dinitrogen pentoxide from its mixture with nitric acid
IPC: C01B21/46
Filed: 1991-07-30
Abstract: PCT No. PCT/GB91/01249 Sec. 371 Date Apr. 16, 1992 Sec. 102(e) Date Apr. 16, 1992 PCT Filed Jul. 15, 1991 PCT Pub. No. WO92/02451 PCT Pub. Date Feb. 20, 1992.Method of extracting dinitrogen pentoxide (N2O5) from its mixture in nitric acid, which consists of providing a solution of the mixture in an inert organic solvent, stripping out the N2O5 from solution in a carrier gas stream containing ozone, and subsequently condensing the N2O5 out of the gas stream by contact with further inert organic solvent. The presence of ozone suppresses the dissociation of the N2O5 transferred to the gas stream into dinitrogen tetroxide (N2O4). In a preferred embodiment the stripping and absorbing steps take place continuously in adjacent stripping and absorbing columns respectively having organic solvent recirculating through each.
Patent FI-20022204-A0 (FI)
Inventor: MERIKOSKI PIA
IPC: D06M/
Filed: 2002-12-16
Abstract: The present invention relates to a method for finishing woollen textiles. According to the method, the woollen textile in an aqueous solution is brought into contact with protease enzyme in a large amount of water so that the woollen textile is moved as little as possible or not at all, at a temperature of about 60° C. or less for 10 to 90 min. The enzyme is inactivated and the woollen textile is taken to dry in mechanical drying at a temperature of about 60° C. or less to reach residual moisture content of 10 to 45%, and the final drying is carried out without mechanics.
Patent FI-20030186-A0 (FI)
IPC: H04L29/08
Filed: 2003-02-06
Abstract: A method and an arrangement are presented for setting up a secure communication connection between a user's mobile station or computer and a service provider's arrangement. The user's mobile station or computer transmits to the service provider's arrangement a connection request that contains an identification of the user placing the connection request. The service provider's arrangement responds with a response message. The user's mobile station or computer transmits to the service provider's arrangement an encryption key to be used in communication between the user's mobile station or computer and a service provider's arrangement, after which secure communication is commenced. There is also conveyed from the service provider to the user's mobile station or computer a computer program for generating cryptographic keys. The user's mobile station or computer uses it to generate cryptographic keys for use in the secure communication between the user's mobile station or computer and the service provider's arrangement.
Patent FI-20090216-A0 (FI)
Inventor: VALKONEN ILKKA
Filed: 2009-05-29
Abstract: The invention relates to a pile which is formed of two or more metal pipe parts (4a, 4b, 4c, 4d, 4e) joined to each other successively and comprising an external thread (6) provided at at least one end (15, 16). The pile further comprises one or more sleeves (3) for joining two successive pipe parts (4a, 4b, 4c, 4d, 4e) to each other. The sleeve (3) comprises a first end (7a) and a second end (7b) as well as a first internal thread (5a) in the vicinity of the first end (7a) and a second internal thread (5b) in the vicinity of the second end (7b). In accordance with the invention, the sleeve (3) comprises at its first and second end (7a, 7b) on the inner surface of the sleeve (3) a plane-like first counter surface (X1). The pipe part (4a, 4b, 4c, 4d, 4e) comprises on its outer surface a second plane-like counter surface (X2). The first and the second plane-like counter surface (X1, X2) are arranged to become positioned tightly against each other when the pipe part (4a, 4b, 4c, 4d, 4e) is in place inside the sleeve (3).
Patent FI-20115539-A0 (FI)
Inventor: HAKOLA JANI
IPC: F16C/
Filed: 2011-06-01
Abstract: The floating roller has a shaft (10) that is rotatably supported on shell (11). A pressure chamber (12) is delimited between the shaft and shell by a sealing arrangement. The sealing gap (14) is provided in the seal structure (13) of sealing arrangement so that the lubricant gas mixture flows between the seal structure and the inner surface (15) of shell. An independent claim is included for method for sealing floating roller.
Patent IL-103570-A0 (IL)
Title: 1,3-dihydro-2h-imidazo(4,5-b)quinolin-2-one derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61P37/08
Filed: 1992-10-28
Abstract: Novel 1,3-dihydro-2H-imidazoÄ4,5-bÜquinolin-2-one derivatives of formula <CHEM> wherein R is hydrogen, C<5> PI 1/4 alkyl, C<7> PI 1/4 cycloalkyl, phenyl optionally substituted with from 1 to 3 substituents each independently selected from halo, hydroxy, C<5> PI 1/4 alkyloxy, C psi  PI 1/4 cycloalkyloxy, C<5> PI 1/4 alkyl or trifluoromethyl; pyridinyl; thienyl optionally substituted with halo or C<5> PI 1/4 alkyl; and     +C=X is a radical of formula    +C=O   (a),    +C=N-O-R<1>   (b), or    +C=CH-R<2>   (c);   the pharmaceutically acceptable addition salts and stereochemically isomeric forms thereof, said compounds being potent inhibitors of both phosphodiesterase III and IV, which are useful in the treatment of allergic disorders, atopic diseases and related afflictions. Intermediates in the preparation thereof. Pharmaceutical compositions containing said compounds as an active ingredient. Methods of preparing said compounds and pharmaceutical compositions.
Patent IL-108818-A0 (IL)
Title: Peptide inhibitors of herpes viral ribonucleotide reductase, their preparation and pharmaceutical compositions containing them
IPC: A61K31/52
Filed: 1994-03-02
Abstract: Disclosed herein are peptide derivatives of the formula A-B-D-NHCH{CH2C(O)R<1>}C(O)-NHCH{CR<2>(R<3>)-COOH}C(O)-E wherein A is a lower alkanoyl bearing two substituents, each substituent selected independently from phenyl or a monosubstituted phenyl wherein the monosubstituent is alkyl, halo, hydroxy or alkoxy; B is a N-methyl amino acid residue; D is an amino acid residue; R<1> is alkyl, cycloalkyl, a monosubstituted amino or a disubstituted amino; R<2> is hydrogen or alkyl and R<3> is alkyl, or R<2> and R<3> are joined to form a cycloalkyl; and E is a terminal unit, for example, an alkylamino or a monovalent amino acid radical such as NHCH(alkyl)C(O)OH. The derivatives are useful for treating herpes infections.
Patent IL-109088-A0 (IL)
Title: Improvements in production of fermented malt beverages
IPC: C12H1/08
Filed: 1994-03-22
Abstract: A process for preparing a fermented malt beverage wherein brewing materials are mashed with water and the resulting mash is heated and wort separated therefrom. The wort is boiled, cooled and fermented and the beer is subjected to a finishing stage, which includes aging, to produce the final beverage. The improvement comprises subjecting the beer to a cold stage comprising rapidly cooling the beer to a temperature of about its freezing point in such a manner that ice crystals are formed therein in only minimal amounts. The resulting cooled beer is then mixed for a short period of time with a beer slurry containing ice crystals, without any appreciable collateral increase in the amount of ice crystals in the resulting mixture. Finally, the so-treated beer is extracted from the mixture.
Patent IL-119152-A0 (IL)
Title: Saw blade-holder
Inventor: FAVRE ROGER
IPC: B23D51/02
Filed: 1996-08-28
Abstract: The saw has a U-shaped frame with an identical blade holder at each end. Each holder consists of a block (35) with a lengthwise passage of the same cross-sectional dimensions as the blade (5) to guide and centre the blade end inserted into it, and has a locking screw (37) situated perpendicular to the passage to fix the blade in place. In a variant of the design the block can incorporate a second locking screw, situated opposite the first one to hold the blade between the tips of the two screws. Each blade holder can be attached to the T-section end (41) of the saw frame by one of the locking screws. The saw frame can be made from tubing, and each blade holder block is of light alloy. The saw handle is of a plastic material, foam-covered to prevent slip.
Patent IL-142181-A0 (IL)
Title: Crystal of diuridine tetraphosphate or salt thereof and method for preparing the same, and method for producing said compound
IPC: C07H19/10
Filed: 1999-10-01
Abstract: The invention provides crystals of P<1>,P<4>-di(uridine 5'-)tetraphosphate or a salt thereof; a process for producing the crystals; and a process for producing P<1>,P<4>-di(uridine 5'-)tetraphosphate (U2P4) or a salt thereof from UMP serving as a starting material and by use of DPC and PPi, which process comprises at least one of the following treatment steps: (a) adding UMP diphenylphosphate (UMP-DPP) in divided portions during a step of reaction of UMP-DPP with a PPi-organic alkali salt; (b) carrying out reaction of UMP-DPP with a PPi-organic alkali salt in the presence of a base; and (c) further treating the synthesized U2P4 with an alkali. The crystals of U2P4 or a salt thereof obtained through the process according to the invention have high purity and stability and a less hygroscopicity as compared with a lyophilized product, to thereby serve as a useful raw material for preparing a pharmaceutical. The process for producing U2P4 or a salt thereof according to the invention realizes high yield and enables large-scale synthesis.
Patent IL-147916-A0 (IL)
Title: Method and apparatus for wireless communications having varying data rates
IPC: H04L12/28
Filed: 2000-07-28
Abstract: The present invention provides an apparatus and method for optimizing power in order to increase capacity. Rather than having any terminal device limited to a specific maximum data rate, instead the terminal device data rate is limited by the power being used, such that the data rate can vary according to the distance that the terminal device is from the intended receiver.
Patent IL-151616-A0 (IL)
Title: Self articulating stent
IPC: A61F2/82
Filed: 2002-09-04
Abstract: A stent is made up of a plurality of adjacent stent segments (2), spaced from one another. Between each two adjacent stent segments is a detachment zone (3) that includes two articulation planes. In each articulation plane there are two connecting members (315), with the members in one articulation plane spaced from those in the other articulation plane about the circumference of the stent by from about 60 to 140 degrees from each other. Within each articulation plane, the two members ne are spaced between about 140 and 220 degrees from each other. <IMAGE>
Patent IL-160422-A0 (IL)
Title: Bv8 nucleic acids and polypeptides with mitogenic activity
IPC: C12N5/06
Filed: 2002-08-27
Abstract: The present invention provides methods of using Bv8 polypeptides to induce endothelial cell proliferation and to enhance endothelial cell survival. Also provided herein are methods of screening for modulators of Bv8 activity. Further more, method of treatment using Bv8 polypeptides are provided.
Patent IL-162590-A0 (IL)
Title: Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
IPC: A61P3/06
Filed: 2002-12-20
Abstract: The invention relates to a terapeutical composition comprising a protein hydrolysate and a plant sterol, wherein the weight ratio of the plant sterol to the protein hydrolysate is from 1:0.02 to 1:150. The invention also relates to a terapeutical composition comprising a protein hydrolysate and a synthetic emulsifier and/or a lipid based gain fraction having emulsifying properties. Said compositions can be used in a pharmaceutical, nutraceutical or food product for improving serum lipid profile.
Patent IL-177694-A0 (IL)
Title: Method, chip, device and system for extraction of biological materials
IPC: C12N1/06
Filed: 2006-08-24
Abstract: The present invention relates to a method, a chip, a device and a system for extraction of biological material form biological cells. The invention involves exposing the biological particles to an alternating electric field in a sample chamber and may also involve subsequent analysis of the biological material after the extraction.